Products & Services

Products & Services

Recent Firm News

  • BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Final Tranche Acquisition - November 5, 2018

    Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the second and final tranche acquisition of remaining operating assets


  • BHC Serves as M&A Adviser to Generex Biotechnology Corporation on Acquisition of Assets - October 11, 2018

    Brooks, Houghton & Company, Inc. ("BHC") is pleased to announce that it advised Generex Biotechnology Corporation ("Generex") (OTCMKTS: GNBT) on the first tranche acquisition of certain operating assets from Veneto


  • Algaia Receives 4 Million Euro Boost - May 22, 2018

    Algaia, S.A., will accelerate development and install a new specialty seaweed extract production unit in its Lannilis (Brittany-France) manufacturing facility dedicated to specialty algae extracts.


Brooks, Houghton & Company, Inc.
780 Third Avenue • 35th Floor • New York, NY 10017 • Phone: (212) 753-1991 • Fax: (212) 753-7730 • info@brookshoughton.com
Securities offered through Brooks Houghton Securities , Inc.
Member FINRA and SIPC

Website Developed by: Smart Interactive Media